Date May 28, 2020
Time 11:00 a.m. – 12:00 p.m. EST
The LinkedIn Live session, hosted by Infosys, will review the challenges and opportunities for the pharma companies in specific and healthcare ecosystem in general in the pandemic era.
The world as we know has changed, and it will never be the same! These are unprecedented times and fast changing developments have had all to reflect and pose challenging questions on business and business models
This session will have the speakers talk about wide range of topics on the impact of COVID-19 and how governments, pharma companies, regulatory bodies, and healthcare system in general are working together to combat the pandemic. It will also explore the new vistas for the industry ahead.
Chief Research Officer, HFS Saurabh Gupta is Chief Research Officer at HFS. He oversees HFS’ global research function managing the global team of analysts across US, Europe, and Asia-Pac. He works closely with the CEO to set the strategic research focus and agenda for HFS Research, understanding and predicting the needs of the industry and ensuring that HFS maintains its position as the strongest impact thought leader for business operations and services research.
SVP and Global Head of Life Sciences, Infosys
Subhro Mallik is the SVP and Head of Life Sciences business unit at Infosys. He leads a team of client partners and sales executives to grow Infosys business in existing and new clients. He brings rich experience of growing new businesses, building teams, and ensuring profitable growth. Subhro was one of the founding members and member of unit leadership team for Infosys Infrastructure Management Services business unit (IMS). He led conceptualization of service offerings and go-to market strategy for IMS. Subhro has been with Infosys since 1998. He has a bachelor degree in engineering from Indian Institute of Technology, Roorkee and completed Infosys Global Leadership Program from Stanford University Graduate School of Business.